Biogen
BIIB
BIIB
1,096 hedge funds and large institutions have $51.9B invested in Biogen in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 419 increasing their positions, 413 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0% less funds holding
Funds holding: 1,100 → 1,096 (-4)
4% less ownership
Funds ownership: 88.82% → 84.82% (-4%)
41% less call options, than puts
Call options by funds: $755M | Put options by funds: $1.28B
Holders
1,096
Holding in Top 10
28
Calls
$755M
Puts
$1.28B
Top Buyers
| 1 | +$193M | |
| 2 | +$192M | |
| 3 | +$115M | |
| 4 |
ClearBridge Investments
New York
|
+$98.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$88.1M |
Top Sellers
| 1 | -$595M | |
| 2 | -$540M | |
| 3 | -$413M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$246M |
| 5 |
D.E. Shaw & Co
New York
|
-$180M |